Skip Nav Destination
Close Modal
Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-5 of 5
Keywords: Adjuvant therapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility
Available to PurchaseSubject Area:
Further Areas
Pietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, Arianna Bettiga, Chiara Re, Giacomo Musso, Francesco Cei, Lucia Salerno, Federico Belladelli, Pierre I. Karakiewicz, Alexandre Mottrie, Alberto Briganti, Andrea Salonia, Chiara Mercinelli, Antonio Cigliola, Andrea Necchi, Francesco Trevisani, Francesco Montorsi, Alessandro Larcher, Umberto Capitanio
Journal:
Urologia Internationalis
Urol Int (2025)
Published Online: 18 November 2025
... cancer Salvage therapy Adjuvant therapy Renal function Chronic kidney disease Obesity is a growing global health concern, affecting nearly 30% of the US population and approximately one in eight individuals worldwide. Alarmingly, adult obesity rates have doubled since 1990 [ 1‒3 ]. Beyond its...
Journal Articles
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Available to PurchaseAngelika Mattigk, Cristina Cano Garcia, Niklas Klümper, Alexander Cox, Oliver Hahn, Kerstin Junker, Kati Erdmann, Philipp Schmucker, Luka Flegar, Friedemann Zengerling, Severine Banek, Jörg Ellinger, Bjoern Thorben Buerk, Johannes Huber, Charis Kalogirou, Philip Zeuschner, Benedikt Hoeh
Journal:
Urologia Internationalis
Urol Int (2025) 109 (3): 291–298.
Published Online: 24 December 2024
... Adjuvant therapy Immunotherapy Renal cell carcinoma Real-world data For localized and locally advanced renal cell carcinoma (RCC), partial or radical nephrectomy remains the curative treatment of choice. However, a quarter of these patients will relapse over time [ 1 ]. Pathological...
Journal Articles
Evaluation of the Management of Urachal Carcinoma: A Single-Center Experience over 13 Years
Available to Purchase
Journal:
Urologia Internationalis
Urol Int (2024) 108 (6): 508–516.
Published Online: 22 July 2024
... was 67.1 ± 9.1 (ranging from 49.3 to 84.9) months. The average relapse-free survival was 48.8 ± 9.9 (ranging from 29.5 to 68.2) months. Six patients received adjuvant therapy, mainly chemotherapy. Five patients died during follow-up. Conclusions: Early physical examination may be helpful for early...
Journal Articles
Subject Area:
Further Areas
Guangjun Shao, Chunru Xu, Jikai Liu, Xuesong Li, Luchao Li, Xiaofeng Li, Xiaoqing Zhang, Yidong Fan, Liqun Zhou
Journal:
Urologia Internationalis
Urol Int (2022) 106 (2): 199–208.
Published Online: 25 August 2021
..., instructions or products referred to in the content or advertisements. Urachal carcinoma Extended partial cystectomy Prognosis High-risk TNM stage Positive surgical margin Adjuvant therapy The urachus is a thick fibrous cord and is located preperitoneal in a pyramid-shaped space...
Journal Articles
Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2019) 102 (4): 468–475.
Published Online: 19 March 2019
... and efficacy of this device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated urinary tract infection (UTI) in adults. Patients and Methods: In this multicentre, randomised, parallel group, double-blind, phase IV study, xyloglucan + gelose (n = 20) or placebo (n...